risedronic acid has been researched along with Hemolysis in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghassabian, S | 1 |
| Wright, LA | 1 |
| Dejager, AD | 1 |
| Smith, MT | 1 |
| Ozkurt, ZN | 1 |
| Güliter, S | 1 |
| Keleş, I | 1 |
| Keleş, H | 1 |
2 other studies available for risedronic acid and Hemolysis
| Article | Year |
|---|---|
Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.
Topics: Acetaminophen; Chromatography, High Pressure Liquid; Diazomethane; Drug Stability; Etidronic Acid; H | 2012 |
Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis.
Topics: Bone Density Conservation Agents; Calcium; Etidronic Acid; Female; Furosemide; Hemolysis; Humans; Is | 2005 |